According to the research report by Open source Securities, Mindray Bio-Medical Electronics (300760.SZ) is actively executing a high expenditure plus device strategy. It is carrying out academic activities for energy equipment (energy platform equipment + ultrasonic knife consumables) on a large scale. Surgical consumables are an important part of high-value consumables. The market is large. Considering that the company continues to benefit from the new medical infrastructure, it continuously breaks into high-end hospitals at home and abroad through innovative products. Although medical compliance in China is still in progress, the high-end development of various sectors is constantly advancing. The "Sanray" ecosystem and overall intelligent solutions continue to land, and the "buy" rating is maintained.
开源证券：维持迈瑞医疗“买入”评级，高耗+设备整体解决方案落地与数智化发展可期
Open source Securities: Maintains a "buy" rating for Mindray Bio-Medical Electronics, with expectations for the landing of high expenditure and device overall solutions and intelligent development.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.